iBet uBet web content aggregator. Adding the entire web to your favor.
iBet uBet web content aggregator. Adding the entire web to your favor.



Link to original content: https://pubmed.ncbi.nlm.nih.gov/334223
Nomifensine in Parkinson's disease - PubMed Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1977;4Suppl 2(Suppl 2):187S-190S.
doi: 10.1111/j.1365-2125.1977.tb05751.x.

Nomifensine in Parkinson's disease

P Bedard, J D Parkes, C D Marsden
Clinical Trial

Nomifensine in Parkinson's disease

P Bedard et al. Br J Clin Pharmacol. 1977.

Abstract

1. Eight patients who failed or ceased to respond to levodopa, or who had developed the "on-off" phenomenon were treated additionally with nomifensine. 2. The dosage of nomifensine started at 50 mg, was increased to 150 mg daily, and other medication was continued unchanged. The duration of treatment was from 2-5 months. Assessments were carried out at 2-week intervals using a validated rating scale. 4. Loss of dopaminergic nigrostriatal neurones characterizes Parkinson's disease, and it is probably for this reason that indirect dopamine (DA) agonists, whose actions depend on intact presynaptic mechanisms, are less active. 3. Nomifensine was not shown to be of antiparkinsonian value in these patients but may be of value as an antidepressant in patients with Parkinson's disease.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. J Neurol Neurosurg Psychiatry. 1976 Dec;39(12):1219-21 - PubMed
    1. Psychol Med. 1976 Feb;6(1):23-33 - PubMed
    1. Naunyn Schmiedebergs Arch Pharmacol. 1974;286(1):49-63 - PubMed
    1. J Pharm Pharmacol. 1974 May;26(5):370-1 - PubMed
    1. Eur J Pharmacol. 1971;14(1):47-59 - PubMed

LinkOut - more resources